GH effect on enzyme activity of 11βHSD in abdominal obesity is dependent on treatment duration

European Journal of Endocrinology

Volumn 154, Issue 1, 2006, Pages 69-74

  Sigurjónsdóttir, Helga Á ^b   Koranyi, Josef ^b   Axelson, Magnus ^a   Bengtsson, Bengt Åke ^b   Johannsson, Gudmundur ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GROWTH HORMONE; INSULIN; PLACEBO; HUMAN GROWTH HORMONE; STEROID;

ABDOMINAL RADIOGRAPHY; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ENZYME ANALYSIS; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID ANALYSIS; LONG TERM CARE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SOFT TISSUE RADIOGRAPHY; SUBCUTANEOUS FAT; URINALYSIS; ABDOMINAL OBESITY; ABDOMINAL SUBCUTANEOUS FAT; BEDTIME DOSAGE; BODY COMPOSITION; DOSE TIME EFFECT RELATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; INTRAABDOMINAL FAT; STEROID URINE LEVEL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; 11-BETA-HYDROXYSTEROID DEHYDROGENASES; ABDOMINAL FAT; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; TIME FACTORS;

EID: 32844461501     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02061     Document Type: Article

References (33)

1. Tannin G, Agarwal A, Monder C, New M & White P. The human gene for 11 betahydroxysteroid dehydrogenase. Structure, tissue distribution and chromosomal localization. Journal of Biological Chemistry 1991 266 16653-16658.
2. Yang K, Khalil MW, Strutt BJ & Killinger DW. 11 beta-hydroxy-steroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. Journal of Steroid Biochemistry and Molecular Biology 1997 60 247-253.
3. Bujalska IJ, Kumar S & Stewart PM. Does central obesity reflect 'Cushings's disease of the omentum'? Lancet 1997 349 1210-1213.
4. Katz JR, Mohammed-Ali V, Wood PJ, Yudkin JS & Coppack SW. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clinical Endocrinology 1999 50 63-68.
5. Walker B, Campbell J, Williams B & Edwards C. Tissue-specific distribution of the NAD + -dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Endocrinology 1992 131 970-972.
6. Donovan SJ. 11 beta-Hydroxysteroid dehydrogenase: a link between the dysregulation of cortisol metabolism and hypertension. British Journal of Biomedical Science 1999 56 215-225.
7. Sigurjonsdottir HA, Manhem K, Axelson M & Wallerstedt S. Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. Journal of Human Hypertension 2003 17 125-131.
8. vanUum SH, Hermus AR, Smits P, Thien T & Lenders JW. The role of 11 betahydroxysteroid dehydrogenase in the pathogenesis of hypertension. Cardiovascular Research 1998 38 16-24.
9. Andrew R, Phillips DIW & Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. Journal of Clinical Endocrinology and Metabolism 1998 83 1806-1809.
10. Andrews RC, Herlihy O, Livingstone DEW, Andrew R & Walker BR. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. Journal of Clinical Endocrinology and Metabolism 2002 87 5587-5593.
11. Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R & Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11 beta-hydroxysteroid dehydrogenase type 1 Activity. Journal of Clinical Endocrinology and Metabolism 2002 87 3330-3336.
12. Tomlinson JW, Shina B, Bujalska I, Hewison M & Stewart PM. Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. Journal of Clinical Endocrinology and Metabolism 2002 87 5630-5635.
13. Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR & Monson JP. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology 1994 41 639-648.
14. Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF & Monson JP. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 betahydroxysteroid dehydrogenase activity. Clinical Endocrinology 1998 48 153-162.
15. Moore JS, Monson JP, Kaltsas G, Putignano P, Wood PJ, Sheppard MC, Besser GM, Taylor NF & Stewart PM. Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 1999 84 4172-4177.
16. Liu Y-J, Nakagawa Y, Nasuda K, Saegusa H & Igarashi Y. Effect of growth hormone, insulin and dexamethasone on 11-beta-hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytes. Life Sciences 1996 59 227-234.
17. Toogood AA, Taylor NF, Shalet SM & Monson JP. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. Journal of Clinical Endocrinology and Metabolism 2000 85 1727-1730.
18. Walker BR, Andrew R, MacLeod KM & Padfield PL. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients. Clinical Endocrinology 1998 49 257-263.
19. Dullaart RPF, Ubels FL, Hoogenberg K, Smit AJ, Pratt JJ, Muntinga JHJ, Sluiter WJ & Wolthers BG. Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition. Journal of Clinical Endocrinology and Metabolism 1995 80 3002-3008.
20. Kerstens MN, Riemens SC, Sluiter WJ, Pratt JJ, Wolthers BG & Dullaart RPF. Lack of relationship between 11 beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24 h of insulin infusion in healthy subjects and type 2 diabetic patients. Clinical Endocrinology 2000 52 403-411.
21. Johannsson G, Mårin P, Löon L, Ottosson M, Stenlöf K, Björntorp P, Sjöström L & Bengtsson B-A. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism 1997 82 727-734.
22. Cowdhury B, Sjöström L, Alpsten M, Konstanty J, Kvist H & Löfgren R. A multicompartment body composition technique based on computed tomography. Internal Journal of Obesity 1994 18 219-234.
23. DeFronzo RA, Tobin JD & Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 1979 237 E214-E223.
24. Axelson M, Sahlberg BL & Sjövall J. Analysis of profiles of conjugated steroids in urine by non-exchange separation and gas chromatography-mass spectrometry. Journal of Chromatography 1981 224 355-370.
25. Best R & Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 betahydroxysteroid dehydrogenase in vivo. Clinical Endocrinology 1997 47 231-236.
26. Palermo M, Shackleton CHL, Mantero F & Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology 1996 45 605-611.
27. Stewart PM, Boulton A, Kumar S, Clark PMS & Shackleton CHL. Cortisol metabolism in human obesity: impaired cortisone cortisol conversion in subjects with central adiposity. Journal of Clinical Endocrinology and Metabolism 1999 84 1022-1027.
28. Westerbacka J, Yki-Jarvinen H, Vehkavaara S, Hakkinen AM, Andrew R, Wake DJ, Seckl JR & Walker BR. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. Journal of Clinical Endocrinology and Metabolism 2003 88 4924-4931.
29. Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T & Walker BR. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. Journal of Clinical Endocrinology Metabolism 2003 88 3983-3988.
30. Trainer P, Drake W, Perry L, Taylor N, Besser G & Monson J. Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2001 86 2989-2992.
31. Isidori A, Kaltsas G, Perry L, Burrin J, Besser G & Monson J. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Clinical Endocrinology 2003 58 601-611.
32. Rodriguez-Arnao J, Perry L, Besser G & Ross R. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clinical Endocrinology 1996 45 33-37.
33. Tomlinson JW, Crabtree N, Clark PMS, Holder G, Toogood AA, Shackleton CHL & Stewart PM. Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity. Journal of Clinical Endocrinology and Metabolism 2003 88 2113-2118.